EE200200410A - Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid - Google Patents

Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid

Info

Publication number
EE200200410A
EE200200410A EEP200200410A EEP200200410A EE200200410A EE 200200410 A EE200200410 A EE 200200410A EE P200200410 A EEP200200410 A EE P200200410A EE P200200410 A EEP200200410 A EE P200200410A EE 200200410 A EE200200410 A EE 200200410A
Authority
EE
Estonia
Prior art keywords
starting
preparation
intermediate compounds
compounds
Prior art date
Application number
EEP200200410A
Other languages
English (en)
Estonian (et)
Inventor
Breipohl Gerhard
Holla Wolfgang
Jendralla Heiner
Beck Gerhard
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200410A publication Critical patent/EE200200410A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EEP200200410A 2000-01-28 2001-01-18 Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid EE200200410A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10003586 2000-01-28
PCT/EP2001/000523 WO2001055175A2 (en) 2000-01-28 2001-01-18 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides

Publications (1)

Publication Number Publication Date
EE200200410A true EE200200410A (et) 2003-12-15

Family

ID=7628946

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200410A EE200200410A (et) 2000-01-28 2001-01-18 Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid

Country Status (29)

Country Link
US (2) US20010031858A1 (enExample)
EP (1) EP1254159B9 (enExample)
JP (1) JP4778181B2 (enExample)
KR (1) KR100758141B1 (enExample)
CN (1) CN1176104C (enExample)
AR (1) AR027246A1 (enExample)
AT (1) ATE325810T1 (enExample)
AU (1) AU779722B2 (enExample)
BR (1) BR0107804A (enExample)
CA (1) CA2398497C (enExample)
CZ (1) CZ20022583A3 (enExample)
DE (1) DE60119491T2 (enExample)
DK (1) DK1254159T3 (enExample)
EE (1) EE200200410A (enExample)
ES (1) ES2262632T3 (enExample)
HR (1) HRP20020631A2 (enExample)
HU (1) HUP0301986A2 (enExample)
IL (2) IL150897A0 (enExample)
MX (1) MXPA02006762A (enExample)
NO (1) NO20023577L (enExample)
NZ (1) NZ520427A (enExample)
PL (1) PL356801A1 (enExample)
PT (1) PT1254159E (enExample)
RU (1) RU2250212C2 (enExample)
SK (1) SK10842002A3 (enExample)
TW (1) TWI236481B (enExample)
WO (1) WO2001055175A2 (enExample)
YU (1) YU51202A (enExample)
ZA (1) ZA200205990B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695999A5 (de) 2002-02-28 2006-11-15 Wilex Ag Verfahren zur Herstellung von 3- Amidinophenylalanin-Derivaten.
WO2007065691A2 (en) * 2005-12-07 2007-06-14 Technische Universität München Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins
CN101774942B (zh) * 2010-01-27 2012-08-22 宁波武盛化学有限公司 制备n-乙酰基-dl-环己基甘氨酸的方法
US8558023B2 (en) * 2010-04-20 2013-10-15 Chiral Quest, Inc. Enantioselective process for cycloalkenyl β-substituted alanines
EP2646150A4 (en) * 2010-11-29 2014-10-08 Takasago Perfumery Co Ltd CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR PRODUCING AN OPTICALLY ACTIVE CARBONYL COMPOUND THEREWITH
CN115068469B (zh) * 2022-07-08 2024-02-27 深圳市小分子新药创新中心有限公司 Tigit抑制剂及其应用
CN115612702A (zh) * 2022-10-09 2023-01-17 深圳市茵诺圣生物科技有限公司 L-丙氨酸类非天然氨基酸3-(3-吡啶基)-l-丙氨酸的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US5866685A (en) * 1993-10-15 1999-02-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
ZA953361B (en) * 1994-04-26 1996-01-12 Selectide Corp Factor Xa inhibitors
US5849510A (en) 1994-04-26 1998-12-15 Selectide Corporation Factor Xa inhibitors
SK281432B6 (sk) * 1995-12-20 2001-03-12 Hoechst Marion Roussel, Inc. Spôsob prípravy n-acetyl-(l)-4-kyanofenylalanínu ac-(l)-phe(4- -cn)-oh a n-acetyl-(l)-p-amidinofenylalanín-cyklohexylglycín- -beta-(3-n-metylpyridínium)-alanínu ac-(l)-paph-chg-palme(3)-nh2
DE19856443A1 (de) 1998-12-08 2000-06-21 Centeon Pharma Gmbh Stabilisiertes Antithrombin III-Präparat

Also Published As

Publication number Publication date
WO2001055175A2 (en) 2001-08-02
JP4778181B2 (ja) 2011-09-21
CN1176104C (zh) 2004-11-17
NO20023577D0 (no) 2002-07-26
SK10842002A3 (sk) 2003-04-01
CA2398497A1 (en) 2001-08-02
WO2001055175A3 (en) 2002-02-21
ZA200205990B (en) 2003-04-30
EP1254159B1 (en) 2006-05-10
AR027246A1 (es) 2003-03-19
PL356801A1 (en) 2004-07-12
IL150897A0 (en) 2003-02-12
MXPA02006762A (es) 2002-10-23
DE60119491D1 (de) 2006-06-14
CN1396928A (zh) 2003-02-12
KR20030019306A (ko) 2003-03-06
RU2250212C2 (ru) 2005-04-20
JP2003523364A (ja) 2003-08-05
EP1254159A2 (en) 2002-11-06
AU4051601A (en) 2001-08-07
KR100758141B1 (ko) 2007-09-13
DE60119491T2 (de) 2006-11-16
NZ520427A (en) 2004-02-27
BR0107804A (pt) 2002-10-22
PT1254159E (pt) 2006-07-31
ATE325810T1 (de) 2006-06-15
ES2262632T3 (es) 2006-12-01
US20040225109A1 (en) 2004-11-11
US20010031858A1 (en) 2001-10-18
TWI236481B (en) 2005-07-21
HK1051866A1 (en) 2003-08-22
RU2002123046A (ru) 2004-01-10
IL150897A (en) 2008-08-07
NO20023577L (no) 2002-08-28
US7084250B2 (en) 2006-08-01
CZ20022583A3 (cs) 2002-10-16
HRP20020631A2 (en) 2004-12-31
CA2398497C (en) 2011-04-26
EP1254159B9 (en) 2006-06-28
AU779722B2 (en) 2005-02-10
DK1254159T3 (da) 2006-09-11
HUP0301986A2 (hu) 2003-09-29
YU51202A (sh) 2005-11-28

Similar Documents

Publication Publication Date Title
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
EE200200704A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200200470A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
EE05223B1 (et) Triasoloprimidiini hendid, meetod nende valmistamiseks ning nende kasutamine
FI20011621A0 (fi) Menetelmä sitalopraamin valmistamiseksi
NO20011272D0 (no) FremgangsmÕte for fremstilling av ren citalopram
NO20011271A (no) Fremgangsmåte for fremstilling av ren citalopram
NO20023928L (no) Fremgangsmåte ved fremstillingen av citalopram
NO20024007L (no) Fremgangsmåte ved fremstillingen av citalopram
EE200100574A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
DE60121150D1 (de) Verfahren zur herstellung von ansamitocin
EE05308B1 (et) Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
NO20024180L (no) Fremgangsmåte ved fremstillingen av citalopram
EE200200697A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20024213L (no) FremgangsmÕte ved fremstilling av citalopram
IL154088A0 (en) Polymorphs of zaleplon and methods for the preparation thereof
EE200100573A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20031927L (no) Forbedret fremgangsmåte for fremstilling av gabapentinmellomprodukt
NO20024214L (no) Fremgangsmåte ved fremstilling av citalopram
NO20023577L (no) Fremgangsmåte for fremstilling av acetyl-amidinofenylalanyl- cykloheksylglycyl-pyridinioalaninamider
NO20033356D0 (no) Fremgangsmåte for fremstilling av DTPA-monoamider